Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
AD ›
ADHUMA
Trademark search for:
ADHUMA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-03-09 — Application filed
2021-03-12 — Application filed
2021-06-08 — Application filed
2021-08-13 — Assigned to examiner
2021-08-13 — Approved for pub - principal register
2021-09-01 — Notification of notice of publication e-mailed
2021-09-21 — Published for opposition
2021-09-21 — Official gazette publication confirmation e-mailed
2021-11-10 — Teas revoke/app/change addr of atty/dom rep received
2021-11-10 — Attorney/dom.rep.revoked and/or appointed
2021-11-10 — Teas withdrawal of attorney received-firm retains
2021-11-10 — Teas change of correspondence received
2021-11-16 — Noa e-mailed - sou required from applicant
2022-05-16 — Notice of allowance cancelled
2022-06-20 — Application abandoned
2022-06-21 — Application abandoned
2022-06-22 — Teas petition to revive received
2022-06-22 — Petition to revive-granted
2022-06-22 — Notice of revival - e-mailed
2022-07-29 — Case assigned to intent to use paralegal
2022-07-29 — New noa to issue
2022-09-06 — Noa e-mailed - sou required from applicant
2023-02-22 — Sou teas extension received
2023-02-22 — Sou extension 1 filed
2023-02-22 — Sou extension 1 granted
2023-02-24 — Notice of approval of extension request e-mailed
2023-09-01 — Sou teas extension received
2023-09-01 — Sou extension 2 filed
2023-09-01 — Sou extension 2 granted
2023-09-01 — Sou teas extension received
2023-09-05 — Notice of approval of extension request e-mailed
2023-09-05 — Early extension of use refused
2024-03-01 — Sou teas extension received
2024-03-01 — Sou extension 3 filed
2024-03-01 — Sou extension 3 granted
2024-03-02 — Notice of approval of extension request e-mailed
2024-08-27 — Sou teas extension received
2024-08-27 — Sou extension 4 filed
2024-08-27 — Sou extension 4 granted
2024-08-27 — Notice of approval of extension request e-mailed
2025-02-19 — Sou extension 5 filed
2025-02-20 — Sou teas extension received
2025-11-11 — Final status recorded
2025-11-12 — Case assigned to intent to use paralegal
2025-11-12 — Sou extension 5 granted
2025-11-12 — Application abandoned
2025-11-12 — Application abandoned
2025-11-12 — Notice of approval of extension request e-mailed
Owner Information
Teva Pharmaceuticals USA, Inc.
Parsippany , NJ
Teva Pharmaceuticals USA, Inc.
Parsippany , NJ
Correspondent
Laurence Rickles TEVA PHARMACEUTICALS USA, Inc. 400 Interpace Parkway Building A Parsippany, NJ 07054
Filing Details
Filing Date:
2021-03-09
Status Date:
2025-11-11
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.